Treatment with Imatinib is generally well-tolerated, and in the majority of patients side effects are only represented by mild to moderate haematological toxicity (Druker 2001). However, a wide spectrum of cutaneous reaction related to imatinib administration has been reported in recent literature. In this chapter, a thorough description of cutaneous adverse events related to Imatinib treatment is provided and the pathogenetics hypothesis will be discussed.
Cutaneous Adverse Events Related To Treatment With Imatinib
SAVOIA, Paola;FAVA, PAOLO
2014-01-01
Abstract
Treatment with Imatinib is generally well-tolerated, and in the majority of patients side effects are only represented by mild to moderate haematological toxicity (Druker 2001). However, a wide spectrum of cutaneous reaction related to imatinib administration has been reported in recent literature. In this chapter, a thorough description of cutaneous adverse events related to Imatinib treatment is provided and the pathogenetics hypothesis will be discussed.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
978-1-62808-304-0_eBook Imatinib.pdf
Accesso riservato
Tipo di file:
PDF EDITORIALE
Dimensione
3.6 MB
Formato
Adobe PDF
|
3.6 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
